Materials and methods A Prioritisation Panel representing a wide range of stakeholders was convened. A master list of services was achieved through matching against criteria (including high cost individual care, growth or implementation that exceeded an incremental cost of £50,000, uncertainty about evidence or ability to benefit) for evidence and prioritisation. Condition-Treatment pairs were ...

Abstract Background During the arrival of COVID-19 pandemic, various professional ethical guidance was issued to (and for) health and social care professionals in England Wales. Guidance can help inform support such their patients, clients service users, but a plethora risked information overload, confusion, inconsistency. Methods early months we undertook rapid review, asking: what are princip...

Objectives: For rare diseases it may be difficult to generate data from randomized trials to support funding of a drug. Enzyme replacement therapies for diseases of inherited metabolic enzyme deficiency provide an example of this dilemma. The Ontario Public Drug Programs convened the Drugs for Rare Diseases Working Group to develop a policy for assessing these drugs. Methods: The Drugs for Rare...

OBJECTIVES To analyze the prioritization process for chemotherapy drugs in the Drug-Therapeutic Committees (DTCs) in Catalan hospitals and assess their impact on patients' access to these drugs. METHODS A case qualitative study of the DTCs of tertiary hospitals in Catalonia was performed, based on semi-structured interviews and a review of the scientific literature. Key professionals were int...